Education and Training
Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy
This randomized, pilot phase I trial studies whether phone or email reminders increases vaginal dilator use in patients with endometrial, cervical, or vaginal cancers after they undergo brachytherapy. Brachytherapy is a type of internal radiation which uses radioactive material placed directly into or near a tumor to kill tumor cells. A reminder program may help increase use of vaginal dilators and decrease long-term side effects following brachytherapy.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- other: survey administration
- other: computer-assisted intervention
- behavioral: telephone-based intervention
Eligibility
Inclusion Criteria:
- Patients with gynecologic cancer who are undergoing vaginal brachytherapy as part of
their treatment
- Patients cannot have previously received pelvic external beam radiation or
brachytherapy. Patients may be enrolled while undergoing vaginal brachytherapy
radiation treatment.
- Patients should have a life expectancy of at least 1 year
- No Eastern Cooperative Oncology Group (ECOG) or Karnofsky performance status
requirements
- No organ and marrow function requirements
- Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria:
- Patients who have received prior pelvic external beam radiation or brachytherapy will
be excluded
- No restrictions regarding use of other investigational agents
- No exclusion requirements due to co-morbid disease or intercurrent illness
- No investigational agent, so no exclusion requirements regarding history of allergic
reactions attributed to compounds of similar chemical or biologic composition to
investigational agent or device
- No exclusion criteria relating to concomitant medications
- No exclusion criteria for pregnant or nursing patients from participating in this
study (Of note, pregnant patients will not be treated with vaginal brachytherapy, a
requirement for enrolling on this study)
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
Female
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Dylann Fujimoto
650-723-8843
Not Recruiting